Waiting times and referral criteria vary by region
This finding indicate that current fasting guidelines may be insufficient for patients on GLP-1 RAs, thereby increasing their aspiration risk [19]
Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further
[67] CHIP, Medicaid, and Medicare Coverage [edit] In April 2025, the Trump Administration declined to finalize a Biden Administration proposal that would have required Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) to broadly cover GLP-1 drugs for weight loss
The review also highlights the role of fiber and probiotics in improving bowel regularity and easing gastrointestinal side effects, along with thermogenics like caffeine or green tea, which may help increase energy
Inhibition of Src abolished these effects, confirming its upstream role